Based on our analysis of z-score using the Pan TCGA data from cBioPortal, we found that CRC samples with high DYRK1A expression levels have significantly lower progression free survival rate (Figure 13a); however, for other DYRKs, no significant change in PFS was observed (Figure 13b–d). The gene discussed is DYRK1A; the disease is colorectal carcinoma.